Patients and providers found common ground on the importance of correct billing estimates but did not see eye to eye in terms of digital scheduling tool use, according to a new survey by Experian Health.

Giant Eagle also helped EmpiRx Health create a national pharmacy care network that was purpose-built for pharmacy and grocery chains.

Researchers in Taiwan find no difference in fungal disease among patients treated with two different types of GVHD prophylaxis.

There is a lack of agreement on the clinical, psychological and social relevance of menopause between the transgender and gender diverse communities and medical professionals, according to the results of a study published this month in Menopause.

Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for short-bowel syndrome.

Researchers of a new JAMA study said that without further participation in accountable care organizations, including the ACO REACH model, the program is unlikely to meet its goal of reducing health disparities.

Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.

CVS Health released a statement shortly after HB1150 was signed in Arkansas, prohibiting pharmacy benefit managers from owning pharmacies.

Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.

On lobbying, hospitals, PBM reform and 340B

In 2024, top issues included daily work activities, work-life balance and conflict with managers. Now in 2025, those concerns have evolved into broader, more alarming themes: workplace stress, interpersonal conflict and performance issues.

In a recent discussion with Managed Healthcare Executive, three leading dermatologists and itch experts—Shawn Kwatra, M.D., Brian Kim, M.D., and Gil Yosipovitch, M.D.—shared where the science is going, what’s holding it back and how the healthcare system can better support patients.

Women who undergo menopause before the age of 40 are more likely to experience cognitive decline, which may lead to dementia, according to new research.

The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.

Here’s what you missed this week on Managed Healthcare Executive.

Having a child recipient and helping someone in need – especially if they knew them – were among the top reasons that people would consider living kidney donation, a new study found.

Maureen Corcoran, director of the Ohio Department of Medicaid, believes the work requirement policy can be both a financial and moral effort to improve the lives of Medicaid consumers.

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden and debilitating hives and recurring itch.

Medicaid is the main healthcare coverage for people living with HIV in the United States, according to data compiled by KFF.

With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the Health Policy Division at the Urban Institute, said it’s more important than ever to understand how those changes could unintentionally cause harm, particularly when data systems fall short and public awareness is limited.

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Oncologists should ask in advance about what young patients and their parents want to be told about changing prognoses, a new qualitative study finds

New research shows that Medicaid expansion was linked to a 2.1% increase in timely lung cancer surgeries and a 2.8% rise in procedures at high-volume hospitals, highlighting how policy changes can impact cancer care access.